L-DEP and PD-1 antibody

DRUG2 trials

Sponsors

Beijing Friendship Hospital

Conditions

Epstein-Barr VirusHemophagocytic LymphohistiocytosisLymphomaPD-1 Antibody

Phase 3

L-DEP/DEP Regimen and PD-1 Antibody as a Treatment for Relapse/Refractory EBV-HLH

Not yet recruitingNCT05315336

Beijing Friendship HospitalHemophagocytic Lymphohistiocytosis

Start: 2022-06-01End: 2026-06-01Target: 50Updated: 2022-04-26

Unknown Phase

L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH

CompletedNCT05775705

Beijing Friendship HospitalEpstein-Barr Virus, Hemophagocytic Lymphohistiocytosis, Lymphoma +1

Start: 2023-08-01End: 2026-08-01Updated: 2026-09-16